5月12日 - ** 手术工厂运营商 Surgery Partners SGRY.O第一季度业绩公布后，股价上涨 3.8%，至 23 美元。
** 公司第一季度营收同比增长 8.2% 至 7.76 亿美元
** 税息折旧及摊销前利润（EBITDA）增长 6.6%，达到 1.039 亿美元
** 首席财务官戴夫-多尔蒂（Dave Doherty）表示，第一季度的业绩增强了在不确定性中重申财政年度指导的信心。
** 12位分析师中有9位将股票评级定为 "买入 "或更高，3位为 "持有"；PT中值为33美元 - LSEG
** 随着盘中走势，SGRY今年以来上涨了9.4%，而纳斯达克指数.IXIC下跌了3.9%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.